NDC 0002-4454-01 - Zyprexa
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0002-4454
- Requested NDC
- 0002-4454-01
- Package NDCs from labels
- 0002-4454-01, 0002-4454-85
- Manufacturer
- Eli Lilly and Company
- Effective date
- 2025-11-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zyprexa - Eli Lilly and Company | Eli Lilly and Company | 2025-11-18 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0002-4454-01 | ZYPREXA Zydis | 1 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 1 | 67 | |
| 0002-4454-01 | ZYPREXA Zydis | 1 in 1 DOSE PACK | TABLET, ORALLY DISINTEGRATING | 1 | 67 | |
| 0002-4454-85 | ZYPREXA Zydis | 30 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 30 | 67 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0002-4454 | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ] | 66 | Legacy NDC, 3 package rows | 20250110_d5051fbc-846b-4946-82df-341fb1216341.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0002-4454-01 | EA - Each | 0002-4454 | 7e221558-7584-4b8b-b359-bbce11fe7e20 | 1 | 2012-07-24 |
| 0002-4454-85 | EA - Each | 0002-4454 | 9879037d-1deb-4639-8596-ead22339987d | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| e l f Camo Semi Matte CC SPF 30 Medium 310 C | ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | e.l.f. Cosmetics, Inc. | 8d53abee-73bc-4268-b08d-0c196ff4d852 | 2025-10-31 | Warnings | 15FIX9V2JP |
| e l f Camo Semi Matte CC SPF 30 Medium 375 N | ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | e.l.f. Cosmetics, Inc. | 1de296f5-276b-4e8f-8db2-78ea01965c4a | 2025-10-31 | Warnings | 15FIX9V2JP |
| e l f Camo Semi Matte CC SPF 30 Rich 610 N | ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | e.l.f. Cosmetics, Inc. | 75543b93-8ed9-4c7b-9fcf-99745df5a194 | 2025-10-31 | Warnings | 15FIX9V2JP |
| e l f Camo Semi Matte CC SPF 30 Rich 620 W | ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | e.l.f. Cosmetics, Inc. | 798eecb3-ff6e-46d1-9053-b40e9cd02e5c | 2025-10-31 | Warnings | 15FIX9V2JP |
| e l f Camo Semi Matte CC SPF 30 Rich 640 W | ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | e.l.f. Cosmetics, Inc. | cbf949b3-e640-48eb-acf6-fccd6f258865 | 2025-10-31 | Warnings | 15FIX9V2JP |
| e l f Camo Semi Matte CC SPF 30 Rich 650 C | ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | e.l.f. Cosmetics, Inc. | b8bfad36-54b7-42f3-bb5b-5eda1a10f021 | 2025-10-31 | Warnings | 15FIX9V2JP |
| e l f Camo Semi Matte CC SPF 30 Rich 660 N | ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | e.l.f. Cosmetics, Inc. | 853100ea-a9dc-43eb-9715-125b543d2be0 | 2025-10-31 | Warnings | 15FIX9V2JP |
| e l f Camo Semi Matte CC SPF 30 Tan 400 W | ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | e.l.f. Cosmetics, Inc. | e4f2b579-4886-4e20-a527-c033e9d60bf5 | 2025-10-31 | Warnings | 15FIX9V2JP |
| e l f Camo Semi Matte CC SPF 30 Tan 460 W | ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | e.l.f. Cosmetics, Inc. | 49255019-fa24-4667-b527-ef7189a51f12 | 2025-10-31 | Warnings | 15FIX9V2JP |
| Clove Hill Tinted Mineral Sunscreen SPF 40 | TITANIUM DIOXIDE, ZINC OXIDE | Clove Hill LLC | eb2ff5a7-384f-4379-b149-47c1c8c2291d | 2025-10-30 | Warnings | 15FIX9V2JP |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | AmerisourceBergen Drug Corporation | f161e151-4fab-2fbc-e053-2a95a90a5437 | 2025-10-30 | Warnings | 1K09F3G675 |
| REMEDY Calazime Skin Protectant | CALAMINE, MENTHOL, WHITE PETROLATUM, ZINC OXIDE | Medline Industries, LP | 1295cfcc-5b61-481b-964b-f53ffd0cb58e | 2025-10-30 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Meijer Distribution Inc. | 03c46823-0b1f-4101-e063-6294a90aaf94 | 2025-10-30 | Warnings | 1K09F3G675 |
| Tinted Mineral Lip Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Clove Hill LLC | a37db64d-8b79-40f4-843f-f38949c5b9d2 | 2025-10-30 | Warnings | 15FIX9V2JP |
| Olanzapine | OLANZAPINE | Qilu Pharmaceutical Co., Ltd. | 12ce860a-6f22-4db6-8acf-786b40f5a5a5 | 2025-10-30 | Boxed warning, Warnings, Adverse reactions | 485968 N7U69T4SZR |
| Sorbitol-Mannitol | SORBITOL AND MANNITOL | ICU Medical Inc. | 5b44e248-4b7b-4777-954a-921c7b309944 | 2025-10-30 | Warnings, Adverse reactions | 3OWL53L36A |
| Aveeno Anti-Itch Concentrated | ZINC OXIDE, FERRIC OXIDE RED, AND PRAMOXINE HYDROCHLORIDE | Kenvue Brands LLC | 07f4d4d0-9cee-46c3-bc71-2024abd31c9e | 2025-10-29 | Warnings | 1K09F3G675 |
| MOOYAM Dark Skin Sunscreen | SUNSCREEN | Guangdong Bisutang Biotechnology Co., LTD | 4246e9f1-1c51-d888-e063-6394a90abda0 | 2025-10-29 | Warnings | 15FIX9V2JP |
| non-tinted mineral sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Clove Hill LLC | 311b270f-b9e2-2374-e063-6294a90af581 | 2025-10-29 | Warnings | 15FIX9V2JP |
| Perricone MD Neuropeptide Restorative Neck and Chest Therapy Broad Spectrum SPF 25 | TITANIUM DIOXIDE | THG Beauty USA LLC | 23f4cf41-0eed-2df3-e063-6294a90ad402 | 2025-10-28 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.